DANIEL BRADBURY - 04 Nov 2021 Form 4 Insider Report for CASTLE BIOSCIENCES INC (CSTL)

Role
Director
Signature
/s/ Greg Acosta, Attorney-in-fact
Issuer symbol
CSTL
Transactions as of
04 Nov 2021
Net transactions value
-$271,428
Form type
4
Filing time
08 Nov 2021, 16:35:09 UTC
Previous filing
25 Oct 2021
Next filing
10 Nov 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CSTL Common Stock Sale $134,847 -2,223 -0.89% $60.66 248,770 04 Nov 2021 By LLC F1, F2, F3
transaction CSTL Common Stock Sale $67,943 -1,112 -0.81% $61.10 136,669 04 Nov 2021 By Daniel Bradbury Irrecovable Descendant's Trust F1, F4, F5
transaction CSTL Common Stock Sale $68,638 -1,111 -0.81% $61.78 136,693 04 Nov 2021 By Annette Bradbury Irrecovable Descendant's Trust F1, F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted collectively by BioBrit, LLC (the "LLC"), The Annette E. Bradbury Irrevocable Descendants' Trust, and The Daniel M. Bradbury Irrevocable Descendants' Trust on May 26, 2021.
F2 This transaction was executed in multiple trades at prices ranging from $60.01 to $60.96, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 Held by the LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares.
F4 This transaction was executed in multiple trades at prices ranging from $60.96 to $61.31, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries.
F6 This transaction was executed in multiple trades at prices ranging from $61.31 to $62.07, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F7 Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries.